{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T10:27:02Z","timestamp":1745836022748},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,9,27]],"date-time":"2006-09-27T00:00:00Z","timestamp":1159315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2007,6,20]]},"DOI":"10.1007\/s10549-006-9389-3","type":"journal-article","created":{"date-parts":[[2006,9,26]],"date-time":"2006-09-26T12:56:57Z","timestamp":1159275417000},"page":"67-74","source":"Crossref","is-referenced-by-count":15,"title":["The 3\u2032 untranslated region C\u00a0&gt;\u00a0T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation"],"prefix":"10.1007","volume":"104","author":[{"given":"Anna","family":"Jakubowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Gronwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohdan","family":"G\u00f3rski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Huzarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Byrski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Benner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Lubi\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney J.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Hamann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,9,27]]},"reference":[{"key":"9389_CR1","doi-asserted-by":"crossref","unstructured":"Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Birch JM, Lindblom A, Stoppa-Lyonnet D, Bignon Y, Borg A, Hamann U, Haites N, Scott RJ, Maugard CM, Vasen H, Seitz S, Cannon-Albright LA, Schofield A, Zelada-Hedman M, the Breast Cancer Linkage Consortium (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676\u2013689","DOI":"10.1086\/301749"},{"key":"9389_CR2","doi-asserted-by":"crossref","unstructured":"King MC, Marks JH, Mandell JB for New York Breast Cancer Study Group (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643\u2013646","DOI":"10.1126\/science.1088759"},{"key":"9389_CR3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","volume":"73","author":"EB Claus","year":"1994","unstructured":"Claus EB, Risch N, Thompson WD (1994) Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 73:643\u2013651","journal-title":"Cancer"},{"key":"9389_CR4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ajmg.1320560305","volume":"56","author":"DF Easton","year":"1995","unstructured":"Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56:265\u2013271","journal-title":"Am J Hum Genet"},{"key":"9389_CR5","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1086\/302922","volume":"66","author":"B Gorski","year":"2000","unstructured":"Gorski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, Pluzanska A, Bebenek M, Fischer-Maliszewska L, Grzybowska E, Narod SA, Lubinski J (2000) Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet 66:1963\u20131968","journal-title":"Am J Hum Genet"},{"key":"9389_CR6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ijc.20162","volume":"110","author":"B Gorski","year":"2004","unstructured":"Gorski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, Mackiewicz A, Stawicka M, Bebenek M, Sorokin D, Fiszer-Maliszewska L, Haus O, Janiszewska H, Niepsuj S, Gozdz S, Zaremba L, Posmyk M, Pluzanska M, Kilar E, Czudowska D, Wasko B, Miturski R, Kowalczyk JR, Urbanski K, Szwiec M, Koc J, Debniak B, Rozmiarek A, Debniak T, Cybulski C, Kowalska E, Toloczko-Grabarek A, Zajaczek S, Menkiszak J, Medrek K, Masojc B, Mierzejewski M, Narod SA, Lubinski J (2004) A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 110:683\u2013686","journal-title":"Int J Cancer"},{"key":"9389_CR7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0888-7543(91)90126-Y","volume":"11","author":"JJ White","year":"1991","unstructured":"White JJ, Ledbetter DH, Eddy RL Jr, Shows TB, Stewart DA, Nuell MJ, Friedman V, Wood CM, Owens GA, McClung JK, Danner DB, Morton CC (1991) Assignment of the human prohibitin gene (PHB) to chromosome 17 and identification of a DNA polymorphism. Genomics 11:228\u2013230","journal-title":"Genomics"},{"key":"9389_CR8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/gcc.2870110109","volume":"11","author":"MA Nagai","year":"1994","unstructured":"Nagai MA, Yamamoto L, Salaorni S, Pacheco MM, Brentani MM, Barbosa EM, Brentani RR, Mazoyer S, Smith SA, Ponder BA, Mulligan LM (1994) Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours. Genes Chromosomes Cancer 11:58\u201362","journal-title":"Genes Chromosomes Cancer"},{"key":"9389_CR9","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1038\/sj.onc.1202684","volume":"18","author":"S Wang","year":"1999","unstructured":"Wang S, Nath N, Adlam M, Chellappan S (1999) Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene 18:3501\u20133510","journal-title":"Oncogene"},{"key":"9389_CR10","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.1128\/MCB.19.11.7447","volume":"19","author":"S Wang","year":"1999","unstructured":"Wang S, Nath N, Fusaro G, Chellappan S (1999) Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals. Mol Cell Biol 19:7447\u20137460","journal-title":"Mol Cell Biol"},{"key":"9389_CR11","doi-asserted-by":"crossref","first-page":"47853","DOI":"10.1074\/jbc.M305171200","volume":"278","author":"G Fusaro","year":"2003","unstructured":"Fusaro G, Dasgupta P, Rastogi S, Joshi B, Chellappan S (2003) Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J Biol Chem 278:47853\u201347861","journal-title":"J Biol Chem"},{"key":"9389_CR12","first-page":"5251","volume":"63","author":"S Manjeshwar","year":"2003","unstructured":"Manjeshwar S, Branam DE, Lerner MR, Brackett DJ, Jupe ER (2003) Tumor suppression by the prohibitin gene 3\u2032 untranslated region RNA in human breast cancer. Cancer Res 63:5251\u20135256","journal-title":"Cancer Res"},{"key":"9389_CR13","first-page":"871","volume":"7","author":"ER Jupe","year":"1996","unstructured":"Jupe ER, Liu XT, Kiehlbauch JL, McClung JK, Dell\u2019Orco RT (1996) Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3\u2032 untranslated region mutations. Cell Growth Differ 7:871\u2013878","journal-title":"Cell Growth Differ"},{"key":"9389_CR14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/excr.1996.0120","volume":"224","author":"ER Jupe","year":"1996","unstructured":"Jupe ER, Liu XT, Kiehlbauch JL, McClung JK, Dell\u2019Orco RT (1996) The 3\u2032 untranslated region of prohibitin and cellular immortalization. Exp Cell Res 224:128\u2013135","journal-title":"Exp Cell Res"},{"key":"9389_CR15","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0140-6736(00)04747-4","volume":"357","author":"ER Jupe","year":"2001","unstructured":"Jupe ER, Badgett AA, Neas BR, Craft MA, Mitchell DS, Resta R, Mulvihill JJ, Aston CE, Thompson LF (2001) Single nucleotide polymorphism in prohibitin 39 untranslated region and breast-cancer susceptibility. Lancet 357:1588\u20131589","journal-title":"Lancet"},{"key":"9389_CR16","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0140-6736(02)11043-9","volume":"360","author":"AB Spurdle","year":"2002","unstructured":"Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Newman B, Chenevix-Trench G (2002) Prohibitin 3\u2032 untranslated region polymorphism and breast cancer risk in Australian women. Lancet 360:925\u2013926","journal-title":"Lancet"},{"key":"9389_CR17","first-page":"1273","volume":"12","author":"IG Campbell","year":"2003","unstructured":"Campbell IG, Allen J, Eccles DM (2003) Prohibitin 3\u2032 untranslated region polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 12:1273\u20131274","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9389_CR18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF00553174","volume":"31","author":"DK Lahiri","year":"1993","unstructured":"Lahiri DK, Schnabel B (1993) DNA isolation by a rapid method from human blood samples: effects of MgCl2, EDTA, storage time, and temperature on DNA yield and quality. Biochem Genet 31:321\u2013328","journal-title":"Biochem Genet"},{"key":"9389_CR19","first-page":"59","volume-title":"Categorical data analysis","author":"A Agresti","year":"1990","unstructured":"Agresti A (1990) Categorical data analysis. Wiley, New York, pp 59\u201367"},{"key":"9389_CR20","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/sim.1047","volume":"21","author":"G Heinze","year":"2002","unstructured":"Heinze G, Schemper M (2002) A solution to the problem of separation in logistic regression. Stat Med 21:2409\u20132419","journal-title":"Stat Med"},{"key":"9389_CR21","first-page":"639","volume":"35","author":"S Manjeshwar","year":"2004","unstructured":"Manjeshwar S, Lerner MR, Zang XP, Branam DE, Pento JT, Lane MM, Lightfoot SA, Brackett DJ, Jupe ER (2004) Expression of prohibitin 3\u2032 untranslated region suppressor RNA alters morphology and inhibits motility of breast cancer cells. J Mol Histol 35:639\u2013646","journal-title":"J Mol Histol"},{"key":"9389_CR22","doi-asserted-by":"crossref","unstructured":"Gorski B, Menkiszak J, Gronwald J, Lubinski J, Narod SA (2004) A protein truncating BRCA1 allele with a low penetrance of breast cancer. J Med Genet 41:e130","DOI":"10.1136\/jmg.2004.019430"},{"key":"9389_CR23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10549-005-1409-1","volume":"92","author":"B Gorski","year":"2005","unstructured":"Gorski B, Cybulski C, Huzarski T, Byrski T, Gronwald J, Jakubowska A, Stawicka M, Gozdecka-Grodecka S, Szwiec M, Urbanski K, Mitus J, Marczyk E, Dziuba J, Wandzel P, Surdyka D, Haus O, Janiszewska H, Debniak T, Toloczko-Grabarek A, Medrek K, Masojc B, Mierzejewski M, Kowalska E, Narod SA, Lubinski J (2005) Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat 92:19\u201324","journal-title":"Breast Cancer Res Treat"},{"key":"9389_CR24","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","volume":"286","author":"MC King","year":"2001","unstructured":"King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K, Tait J, Ford L, Dunn BK, Costantino J, Wickerham L, Wolmark N, Fisher B (2001) National surgical adjuvant breast and bowel project. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: national surgical adjuvant breast and bowel project (NSABP-P1) breast cancer prevention trial. JAMA 286:2251\u20132256","journal-title":"JAMA"},{"key":"9389_CR25","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(00)03258-X","volume":"356","author":"SA Narod","year":"2000","unstructured":"Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, Stoppa-Lyonnet D, Lerman C, Pasini B, de los Rios P, Weber B, Lynch H (2000) Hereditary breast cancer clinical study group. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet 356:1876\u20131881","journal-title":"Lancet"},{"key":"9389_CR26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","volume":"340","author":"LC Hartmann","year":"1999","unstructured":"Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340:77\u201384","journal-title":"N Engl J Med"},{"key":"9389_CR27","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","volume":"93","author":"LC Hartmann","year":"2001","unstructured":"Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL, Frost MH, Grant CS, Donohue JH, Woods JE, McDonnell SK, Vockley CW, Deffenbaugh A, Couch FJ, Jenkins RB (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93:1633\u20131637","journal-title":"J Natl Cancer Inst"},{"key":"9389_CR28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","volume":"345","author":"H Meijers-Heijboer","year":"2001","unstructured":"Meijers-Heijboer H, van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, Bartels CC, Verhoog LC, van den Ouweland AM, Niermeijer MF, Brekelmans CT, Klijn JG (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345:159\u2013164","journal-title":"N Engl J Med"},{"key":"9389_CR29","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"22","author":"TR Rebbeck","year":"2004","unstructured":"Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van\u2019t Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22:1055\u20131062","journal-title":"J Clin Oncol"},{"key":"9389_CR30","doi-asserted-by":"crossref","unstructured":"Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van\u2019t Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL, Prevention and Observation of Surgical End Points Study Group (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346:1616\u20131622","DOI":"10.1056\/NEJMoa012158"},{"key":"9389_CR31","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","volume":"346","author":"ND Kauff","year":"2002","unstructured":"Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346:1609\u20131615","journal-title":"N Engl J Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-006-9389-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-006-9389-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-006-9389-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:28:45Z","timestamp":1559233725000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-006-9389-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,27]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,6,20]]}},"alternative-id":["9389"],"URL":"https:\/\/doi.org\/10.1007\/s10549-006-9389-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,27]]}}}